2Guidelines Subcommittee. 1999 world health organization international society of hypertension gudelines for the management of hypertension[J]. J hyperters, 1999,17(2) : 151 -- 183.
3Stjth B J. Woronoff K, Wiernsperger N. Stiulation of the intracellular portion of the human insulin receptor by the antidiabtiie drug etforinn[J]. Biochem Pharmacal,1998,55(7) :533--536.
2King H, Aubert RE, Herman WH. Global burden of diabetes 1995-2025: prevalence, numerical estimates, and prejections. Diabetes Care,1998,21 : 1414-143 1.
3Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care, 2002,25(Suppl 1):S5-20.
4Lee WL, Cheung AM, Cape D, et al. Impact of diabetes on cardiovascular disease in women and men: a meta-analysis of prospective studies. Diabetes Care, 2000,23:962-968.
5Tuomilehto J, Bastenyte D, Jousilahti P, et al. Diabetes mellitus as a risk factor for death from stroke Prospective study of middle-aged Finnish population. Stroke.1996.27:210-215.
6Balkau B, Shipley M, Jarrett RJ, et al. High blood glucose concentration is a risk factor for mortality in middle-aged non-diabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study. Diabetes Care , 1998,21 : 360-367.
7Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of pulished data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care, 1999,22:233-240.
8Tomlnaga M, Eguchi H, Manaka H, et 81. Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care, 1999,22:920-924.
9Bonora E, Kiechl S, Willeit J, et al. Plasma glucose within normal range is not associated with carotid atherosclerosis : prospective results in subjects with normal glucose tolerance from the Bruneck Study. Diabetes Care, 1999,22:1339-1346.
